160 related articles for article (PubMed ID: 36670189)
21. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
[TBL] [Abstract][Full Text] [Related]
22. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
[No Abstract] [Full Text] [Related]
23. Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury.
Gao F; Fang J; Chen F; Wang C; Chen S; Zhang S; Lv X; Zhang J; He Q; Weng S; Liu Q; Lin XH
EBioMedicine; 2016 Jul; 9():324-335. PubMed ID: 27333037
[TBL] [Abstract][Full Text] [Related]
24. Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis.
Aljuhani M; Makati D; Hoff A; Thompson J; Pellegrino B; Shawwa K; Schmidt R; Kannabhiran D
Rheumatol Int; 2021 May; 41(5):965-972. PubMed ID: 33585954
[TBL] [Abstract][Full Text] [Related]
25. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
[TBL] [Abstract][Full Text] [Related]
26. Saint John on Patmos: Revelations of the Role of Antineutrophil Cytoplasmic Antibody (ANCA) in Vasculitis.
Pijnappel EN; Rijkers GT; Overveld FJV
Curr Med Chem; 2020; 27(17):2852-2862. PubMed ID: 31838986
[TBL] [Abstract][Full Text] [Related]
27. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils.
Hess C; Sadallah S; Schifferli JA
Blood; 2000 Oct; 96(8):2822-7. PubMed ID: 11023517
[TBL] [Abstract][Full Text] [Related]
28. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
29. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
[TBL] [Abstract][Full Text] [Related]
30. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.
Bonaci-Nikolic B; Andrejevic S; Pavlovic M; Dimcic Z; Ivanovic B; Nikolic M
Clin Rheumatol; 2010 Aug; 29(8):893-904. PubMed ID: 20306213
[TBL] [Abstract][Full Text] [Related]
31. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
32. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Rodríguez E; Latzke B; Sierra M; Romera AM; Siedel D; Agraz I; Soler MJ; García-Carro C; Draibe J; de la Prada FJ; Villacorta J; Buxeda A; Sierra-Ochoa A; Lozano I; Durán X; Barrios C; Pascual J
Nephrol Dial Transplant; 2022 Mar; 37(4):697-704. PubMed ID: 33533909
[TBL] [Abstract][Full Text] [Related]
33. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
[TBL] [Abstract][Full Text] [Related]
34. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
Holding S; Fisher VJ; Abuzakouk M
Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
[TBL] [Abstract][Full Text] [Related]
35. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.
Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM
Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574
[TBL] [Abstract][Full Text] [Related]
36. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538
[TBL] [Abstract][Full Text] [Related]
37. Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
Flint SM; McKinney EF; Smith KG
Curr Opin Rheumatol; 2015 Mar; 27(2):197-203. PubMed ID: 25629443
[TBL] [Abstract][Full Text] [Related]
38. Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis.
Pearce FA; Craven A; Merkel PA; Luqmani RA; Watts RA
Rheumatology (Oxford); 2017 Nov; 56(11):1962-1969. PubMed ID: 28968886
[TBL] [Abstract][Full Text] [Related]
39. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Toward an Individualized Approach.
Villacorta J; Martinez-Valenzuela L; Martin-Capon I; Bordignon-Draibe J
Nephron; 2022; 146(2):121-137. PubMed ID: 34915506
[TBL] [Abstract][Full Text] [Related]
40. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
